Canabo Medical Inc. (
TSX: V.CMM,
OTCQB: CAMDF,
Forum) commented today on the Federal Government Task Force report on Cannabis Legalization and Regulation, issued by the Canadian federal government. Dr. Neil Smith, the Company’s Executive Chairman, applauded the findings of the task force, specifically “the need for credible, evidence-based research.”
Canabo Medical is an industry leader in collecting data on cannabis usage. The Company currently has a database containing user data on more than 10,000 patients. Further information can be found
here.
Canabo Medical was recently in the news when it announced $8.4 million in equity financing and a
new patient observational study involved more than 7,500 subjects.
The Company has 30 million shares outstanding and a market cap of $28.0 million.
FULL DISCLOSURE: Canabo Medical Corp. is a paid client of Stockhouse Publishing.